NCT00591591

Brief Summary

The goal of this trial is to assess the performance of the OxiplexTS-an absolute near-infrared oximeter-as an instrument to measure brain oxygenation and hemodynamics in sleep medicine as well as in the broader field of cardiovascular/cerebrovascular diagnostics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
309

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Aug 2007

Typical duration for phase_3

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2007

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2007

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 11, 2008

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
9 months until next milestone

Results Posted

Study results publicly available

March 11, 2011

Completed
Last Updated

March 16, 2011

Status Verified

February 1, 2011

Enrollment Period

2.8 years

First QC Date

December 21, 2007

Results QC Date

September 22, 2010

Last Update Submit

March 10, 2011

Conditions

Keywords

Obstructive Sleep Apnea Syndromesleep disordered breathingpolysomnography (psg)continuous positive airway pressure (cpap)brain vascular autoregulationbrain tissue oxygenationnear-infrared spectroscopyObstructive Sleep Apnea

Outcome Measures

Primary Outcomes (4)

  • Percentage of Oxygen Saturation in the Brain During Sleep

    6 hours of sleep

  • Oxyhemoglobin Concentration in the Brain During Sleep

    6 hours of sleep

  • Total Hemoglobin Concentration in the Brain During Sleep

    6 hours of sleep

  • Deoxy-Hemoglobin Concentration in the Brain During Sleep

    6 hours of sleep

Secondary Outcomes (1)

  • Apnea Hypopnea Index (AHI is the Index of Severity That Combines Apneas and Hypopneas) Determined During the Routine Sleep Study

    6 hours of sleep

Study Arms (2)

OSA

EXPERIMENTAL

Persons with suspected obstructive sleep apnea (OSA) undergoning overnight sleep evaluation

Device: OxiplexTS

Controls

NO INTERVENTION

Healthy controls

Interventions

OxiplexTSDEVICE

OxiplexTS is a Frequency Domain Near-Infrared Tissue oximeter which provides absolute values of tissue oxygenation in real time. It also provides physiological quantities of oxy, deoxy and total hemoglobin concentration, which form the basis for the functional measurement of brain hemodynamics. Both the control and OSA groups will undergo standard overnight sleep study (PSG). In addition to the standard PSG, with or without Continuous Positive Airway Pressure (CPAP), we will add the OxiplexTS, allowing us to assess brain oxygenation and hemodynamics during sleep. The hemodynamic patterns of the healthy controls will be compared to the OSA sufferers. Participants with OSA who undergo PSG/CPAP will be also tested with the OxiplexTS. Their PSGs and PSG/CPAP data will be compared.

OSA

Eligibility Criteria

Age21 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy individuals (controls)
  • Individuals undergoing overnight polysomnography foe suspected obstructive sleep apnea

You may not qualify if:

  • Documented severe cardiovascular disease.
  • Documented cerebrovascular disease
  • Documented cardiopulmonary disease
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University of California-Irvine Sleep Disorders Center, 101 The City Drive South, Bldg. 22C, 2nd Floor, Rt. 23

Orange, California, 92868, United States

Location

Stanford Sleep Disorders Clinic, Psychiatry Building, 401 Quarry Road

Stanford, California, 94305, United States

Location

Center of Sleep and Ventilatory Disorders, University of Illinois Medical Center at Chicago, 2200 W Harrison

Chicago, Illinois, 60612, United States

Location

Carle Regional Sleep Disorders Center, Carle Foundation Hospital, 611 West Park Street

Urbana, Illinois, 61801, United States

Location

Related Publications (3)

  • Safonova LP, Michalos A , Wolf U, Wolf M, Mantulin WW, Hueber DM and Gratton E. Diminished cerebral circulatory autoregulation in obstructive sleep apnea investigated by near-infrared spectroscopy. Sleep Research on-line 2003; 5(4): 123-132, 2003.

    BACKGROUND
  • Safonova LP, Michalos A, Wolf U, Wolf M, Hueber DM, Choi JH, Gupta R, Polzonetti C, Mantulin WW, Gratton E. Age-correlated changes in cerebral hemodynamics assessed by near-infrared spectroscopy. Arch Gerontol Geriatr. 2004 Nov-Dec;39(3):207-25. doi: 10.1016/j.archger.2004.03.007.

    PMID: 15381340BACKGROUND
  • Olopade CO, Mensah E, Gupta R, Huo D, Picchietti DL, Gratton E, Michalos A. Noninvasive determination of brain tissue oxygenation during sleep in obstructive sleep apnea: a near-infrared spectroscopic approach. Sleep. 2007 Dec;30(12):1747-55. doi: 10.1093/sleep/30.12.1747.

    PMID: 18246984BACKGROUND

Related Links

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea SyndromesMicrocephaly, Primary Autosomal Recessive, 6

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Results Point of Contact

Title
Antonios Michalos
Organization
ISS, Inc., Champaign Illinois

Study Officials

  • Antonios Michalos, M.D., M.S.

    ISS, Inc.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

December 21, 2007

First Posted

January 11, 2008

Study Start

August 1, 2007

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

March 16, 2011

Results First Posted

March 11, 2011

Record last verified: 2011-02

Locations